Últimas noticias sobre Elicio Therapeutics (NASDAQ:ELTX) Bolsa

Elicio Therapeutics

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ATPC

BDMD

CGBS

CRKN

DWTX

New Oriental Education & Technology Group

ELTX

EONR

FFWM

GOEV

IROQ

ORKT

RSKD

RYAM

SWKH

TMCI

TPET

TTGT

VATE

Descubre las acciones que lideran el premercado con sorprendentes subidas y caídas. INNOVATE y más protagonistas hoy.

Las acciones de INNOVATE (VATE) cotizan un 19% más alto; 20 acciones que se mueven en el premercado de EE.UU.

ALVO

BBGI

BCAX

FOXO

ISPC

JBHT

LYTS

MDXG

NATR

NUKK

OFIX

TXNM

VIAV

WILC

Explora los mayores ganadores y perdedores en las operaciones previas al mercado. Descubre qué impulsó estos movimientos destacados.

Las acciones de Versus Systems (VS) aumentan un 71%; 20 acciones que se mueven en el premercado de EE.UU.

Elicio Therapeutics Inc

An 80-year-old woman packed and ready to move says she's trapped in her apartment because a nonprofit is still holding onto her Social Security benefits — even after the program that once supported her abruptly shut down and gave her just 10 days to leave.
According to a report by <a href="https://youtu.be/-VPe0qo4Zco?si=QXw0fXzvELgktQTJ">WHEC-TV</a> in Rochester, New York, Georgia Johnson is one of many elderly and disabled residents evicted from Hudson Ridge and Danforth Towers in Rochester following the sudden closure of the Enriched Housing Program last month. The program, run by Family Service of Rochester, was supposed to help residents live independently by using their government benefits to pay rent and provide support services.
Don't Miss:
<ul class="wp-block-list">
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/how-peter-thiel-turned-his-roth-ira-into-5-billion-and-why-accredited-investors-are-now-eyeing-this-smartphone-disruptor">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
</ul>
Instead, residents say they were blindsided.
"This country is supposed to be the land of the free and the home of the brave," Johnson said. "But in other countries, they take care of their elders."
Johnson has end-stage congestive heart failure and kidney failure. Though she's mentally sharp, she's physically frail. Her belongings are packed in bins and boxes — but she can't move. She says Family Service of Rochester still controls her money and hasn't returned it.
"How can they be so heartless to take people's money when they have to live?" Johnson asked.
She said the organization promised to refund her May <a href="https://www.benzinga.com/personal-finance/25/05/45665342/social-security-is-the-main-source-of-income-for-retirees-in-these-10-states-is-your-state-on-the-list">Social Security check</a> and told her it would be returned by May 20, but the money never came. Her daughter, Jannine Johnson, helped her file paperwork with the Social Security office to remove Family Service as her representative payee.
"That money was supposed to be put in mommy's account on [June 3]," said Jannine.
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
But it didn't happen, Jannine said. The Social Security Administration mistakenly sent the June check back to Family Service. Johnson was then instructed to get the nonprofit to issue her a check.
She's tried. She's still waiting.
Family Service of Rochester told WHEC in a <a href="https://www.whec.com/top-news/consumer-alert-nonprofit-still-has-seniors-social-security-benefits-after-ending-program/">statement</a> that it is following instructions from the local Social Security office and will continue to act as payee until officially replaced,
Johnson's situation is made worse by the <a href="https://www.benzinga.com/personal-finance/25/05/45602625/78-year-old-florida-woman-on-social-security-has-been-living-in-her-car-for-months-because-she-cant-afford-rent-i-eat-one-meal-a-day-for-2-02">type of housing now being offered</a>.
"Want to hear the shocker?" she said. "They told me — you see all this stuff here? — they told me I was going to be in one room with a partner."
"That wasn't even a downsize. That was a no-size," she added.
Her daughter has found an assisted living facility that could work — if they can access the funds. Until then, Johnson remains stuck in limbo.
The state Department of Health told WHEC that the quality of care provided by the nonprofit was so poor it endangered residents' health and safety. Meanwhile, the Rochester Housing Authority claims Family Service is $400,000 behind in rent payments.
The legal scrutiny is now intensifying.
See Also: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
The Monroe County District Attorney and the New York State Attorney General's Office both confirm they are investigating the situation. The U.S. Attorney's Office has not confirmed whether it has opened a case, according to the report.&nbsp;
WHEC reported that Family Service said it is working with Social Security officials to get Johnson's money returned.
Her story has sparked outrage online, where commenters have called the situation "shameful," "cruel," and "the kind of thing that shouldn't happen in America." Some expressed disbelief that a nonprofit could still act as a payee after shutting down services. Others shared their own experiences trying to help elderly parents reclaim benefits from similar arrangements.
A few offered non-legal suggestions: visiting the <a href="https://www.ssa.gov/agency/contact/phone.html">local SSA office in person</a>, escalating to the fraud department, and involving elected officials who can expedite SSA actions. One user wrote, "My mom got her money back only after we filed a congressional inquiry." Another added, "Keep calling. The squeaky wheel gets the oil."
While Johnson and her daughter continue pushing through the system, the money intended to support her still sits out of reach — held by a service that no longer exists.
Read Next:
<ul class="wp-block-list">
<li>Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/how-peter-thiel-turned-his-roth-ira-into-5-billion-and-why-accredited-investors-are-now-eyeing-this-smartphone-disruptor">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

Personal Finance

'That Wasn't Even a Downsize — That Was a No-Size': 80-Year-Old Says Nonprofit Housing Agency Shut Down But Is Still Getting Her Social Security Check

KKR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) has outperformed the market over the past 15 years by 6.29% on an annualized basis producing an average annual return of 18.2%. Currently, KKR has a market capitalization of $111.54 billion. 
Buying $1000 In KKR: If an investor had bought $1000 of KKR stock 15 years ago, it would be worth $12,278.43 today based on a price of $125.24 for KKR at the time of writing.
<h3>KKR's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749767413_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

Retailer Walmart Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) <a href="https://www.benzinga.com/markets/25/05/45536218/walmart-responds-to-trumps-eat-the-tariff-remark-worked-to-keep-our-prices-as-low-as-possible-and-we-wont-stop">has been battling</a> with the Donald Trump administration over tariffs and may have a new fight on its hands with Trump fans thanks to an heiress of the company's founding family.
What Happened: Walmart and the Trump administration have been going back and forth on tariffs and whether the retailer can publicly say it <a href="https://www.benzinga.com/news/retail-sales/25/06/45829026/walmart-shoppers-see-sharp-price-hikes-as-tariffs-hit-shelves">is passing costs </a>onto consumers.
An additional issue, which could possibly mean the retailer finds itself with fewer customers, is if it battles too hard with Trump fans due to Christy Walton.
Walton is the widow of John T. Walton, son of Walmart founder Sam Walton. The Walmart heiress funded a full-page ad for the "No Kings" movement placed in the New York Times, the New York Post <a href="https://nypost.com/2025/06/11/business/walmart-heiress-christy-waltons-anti-trump-ad-fuels-maga-led-call-for-boycott-of-retailer/">reported</a>.
The ad calls for a nationwide protest against Trump and asks Americans and other citizens to "mobilize" on Saturday, which is Trump's birthday and the day of a large military parade in the nation's capital.
Walton's funded ad also calls on Americans to "reject authoritarianism."
According to the report, the "No Kings" movement is planning around 1,500 nationwide protests on Saturday. The report notes that the movement is not holding a protest in Washington, D.C. on Saturday on purpose.
"The honor, dignity, and integrity of our country are not for sale," the ad reads, alongside a QR code that shows the map of protest locations.
A Christy Walton spokesperson said the ad does not encourage violent protests, but rather to "engage peacefully and civically."
"Christy has provided no funding to organizations or individuals involved in the demonstrations in Los Angeles or other cities, nor has she provided any funding to those organizing the upcoming events," the spokesperson said.
The spokesperson said Walton believes Americans have the right to protest, but not the right to violence.
Read Also: <a href="https://www.benzinga.com/news/politics/25/06/45894541/trump-sports-president-military-birthday-parade">Airtime Denied: Trump B-Day, Military Parade Gets Streaming Treatment</a>
Why It's Important: Walton is not involved in Walmart's operations, but her actions could end up hurting the future growth and revenue of the company her former husband's family founded. She maintains a 1.9% stake in the company.
Walton is worth $18.6 billion according to <a href="https://www.bloomberg.com/billionaires/?sref=TBDibEcD">Bloomberg</a>, ranking 117th among the world's billionaires. This trails other Walton figures like her son Lukas Walton, who is the 39th richest person worth $41.1 billion, and her husband's siblings Jim, Rob and Alice Walton, who rank 13th, 14th and 15th worth $119 billion, $117 billion and $116 billion, respectively.
The White House responded to the ad and brushed aside Walton's criticism.
"Great, a left-wing billionaire feels like burning some of her inheritance for a PR stunt," White House spokesman Kush Desai told The Post.
Desai said the ad would not change the fact that more than 77 million Americans voted for Trump and his "America First trade policies."
Some Trump allies indirectly and directly called for a boycott of Walmart.
White House special adviser Kari Lake shared the ad on X and asked her followers, "Do you shop at Walmart?"
Rep. Anna Paulina Luna (R-Fla.) posted on X that Walton is funding ads for "No Kings Day," while naming her as a Walmart heiress.
"Looks like the Walmart dynasty is big mad about China tariffs," Luna said.
Trump supporter Roger Stone encouraged people to boycott Walmart.
"The Walmart heiress subsidizes insurrection. Next up, peaceful protests outside all of their stores to encourage people not to shop there. Essentially what left-wing stooges did to Tesla," Stone said.
Walmart has tried to distance itself from Walton.
"The advertisement from Christy Walton [is] in no way connected to or endorsed by Walmart," Walmart spokesperson Joe Pennington said.
Pennington said Walton "has no active role in company decisions."
This could end up being an unfortunate situation for Walmart and shareholders as a major boycott effort by Trump fans could impact sales. Walmart locations are often times found in rural locations and small cities that have leaned towards voting for Trump in recent elections.
WMT Price Action: Walmart stock closed down 1.01% to $94.83 on Thursday versus a 52-week trading range of $65.95 to $105.30. Walmart stock is up 5.4% year-to-date in 2025.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/management/25/05/45473067/walmart-prices-will-rise-within-weeks-as-trump-tariffs-drive-up-costs-will-other-retailers-follow-suit">Walmart Prices Will Rise Within Weeks As Trump Tariffs Drive Up Costs: Will Other Retailers Follow Suit?</a></li>
</ul>
Photo: Shutterstock

Politics

Walmart Heiress Takes On Trump With 'No Kings' Ad: White House Calls It 'Burning Some Of Her Inheritance For A PR Stunt'

ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) has outperformed the market over the past 5 years by 6.34% on an annualized basis producing an average annual return of 20.38%. Currently, ServiceNow has a market capitalization of $208.81 billion. 
Buying $100 In NOW: If an investor had bought $100 of NOW stock 5 years ago, it would be worth $256.65 today based on a price of $1008.00 for NOW at the time of writing.
<h3>ServiceNow's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749766512_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In ServiceNow 5 Years Ago Would Be Worth Today

General

CLDX

Celldex Therapeutics Announces 76-Week Results From Barzolvolimab Phase 2 Study In Chronic Spontaneous Urticaria At EAACI Congress 2025; Up To 41% Of Patients Reporting A Complete Response At 76 Weeks And 48% Of Patients Reporting That Their Disease No Longer Impacts Their Quality Of Life; Enrollment to Phase 3 CSU Trials Ongoing

BPMC

Blueprint Medicines Reveals Data Reinforcing Sustained Clinical Efficacy And Well-Tolerated Safety Profile of Long-Term AYVAKIT/AYVAKYT Treatment At 2025 EHA And EAACI Congresses

WIIM

ADBE

ADBE stock has given up its prior gain. Adobe shares were trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 guidance.

<a href="https://www.bloomberg.com/news/articles/2025-06-12/nrg-expects-to-line-up-new-us-data-center-deals-this-quarter?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-06-12/nrg-expects-to-line-up-new-us-data-center-deals-this-quarter?embedded-checkout=true</a>

'NRG Expects to Line Up New US Data Center Deals This Quarter'- Bloomberg

In the current market session, ServiceNow Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) share price is at $1008.00, after a 0.37% increase. Moreover, over the past month, the stock decreased by 2.69%, but in the past year, went up by 38.26%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1749765619_0.png" alt="Past Year Chart" />

<h3>A Look at ServiceNow P/E Relative to Its Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
ServiceNow has a better P/E ratio of 136.27 than the aggregate P/E ratio of 92.8 of the Software industry. Ideally, one might believe that ServiceNow Inc. might perform better in the future than it's industry group, but it's probable that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1749765619_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Price Over Earnings Overview: ServiceNow

UBS Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBS#NYSE">UBS</a>) has outperformed the market over the past 5 years by 10.05% on an annualized basis producing an average annual return of 24.1%. Currently, UBS Gr has a market capitalization of $104.08 billion. 
Buying $1000 In UBS: If an investor had bought $1000 of UBS stock 5 years ago, it would be worth $2,986.29 today based on a price of $32.67 for UBS at the time of writing.
<h3>UBS Gr's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749765613_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

<a href="https://www.axios.com/2025/06/12/israel-strike-iran-us-not-participate">https://www.axios.com/2025/06/12/israel-strike-iran-us-not-participate</a>

iShares MSCI Israel Capped Investable Market Index Fund

'U.S. told Israel it won't participate in an Israeli strike on Iran'- Axios

Offerings

XTIA

XTI Aerospace Files For Firm Commitment Public Offering Of Up To 3.96M Shares Of Common Stock

Earnings

Friedman Industries Q4 EPS $0.76 Up From $0.71 YoY, Sales $129.22M Down From $132.23M YoY

Intercontinental Exchange (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICE#NYSE">ICE</a>) has outperformed the market over the past 15 years by 2.3% on an annualized basis producing an average annual return of 14.2%. Currently, Intercontinental Exchange has a market capitalization of $102.89 billion. 
Buying $100 In ICE: If an investor had bought $100 of ICE stock 15 years ago, it would be worth $731.95 today based on a price of $179.08 for ICE at the time of writing.
<h3>Intercontinental Exchange's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749763821_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today

<a href="https://www.wsj.com/world/middle-east/israel-attack-iran-nuclear-program-ac023cd5?mod=hp_lead_pos1">https://www.wsj.com/world/middle-east/israel-attack-iran-nuclear-program-ac023cd5?mod=hp_lead_pos1</a>

'Israeli Attack on Iran Could Come Within Days, U.S. and Israeli Officials Say'- WSJ

DKNG

DraftKings To Introduce Transaction Fee In Illinois; To Implement 50c Deal Fee On Illinois Bets

QNCX

Quince Therapeutics Reveals Pricing Of Up To $22M Private Placement Of Securities; Financing To Provide $11.5M Upfront, $10.4M From Warrants; Proceeds To Fund Phase 3 Neat Trial And Corporate Purposes

BJ's Wholesale Club Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BJ#NYSE">BJ</a>) has outperformed the market over the past 5 years by 11.42% on an annualized basis producing an average annual return of 25.47%. Currently, BJ's Wholesale Club Hldgs has a market capitalization of $14.48 billion. 
Buying $1000 In BJ: If an investor had bought $1000 of BJ stock 5 years ago, it would be worth $3,237.67 today based on a price of $109.66 for BJ at the time of writing.
<h3>BJ's Wholesale Club Hldgs's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749762911_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In BJ's Wholesale Club Hldgs 5 Years Ago Would Be Worth Today

While the wider business community awaited news regarding <a href="https://www.benzinga.com/news/macro-notification/25/06/45876366/howard-lutnick-says-us-and-china-reached-a-framework-to-implement-geneva-consensus-following-trump-xi-call-csi-300-index-gains">trade negotiations</a> between the U.S. and China, one of the more anxious names may have been Applied Materials Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>). As a semiconductor equipment specialist, Applied Materials represents a vital cog for multiple tech sectors, including computers, smartphones and solar products. However, tensions between the world's top two economies threatened the company's access to critical rare earth minerals.
To be sure, the immediate response to the new trade deal framework — announced on Tuesday following two days of high-level discussions between U.S. and Chinese officials — was muted. While analysts in principle are encouraged by the agreement, which involves both sides rolling back contentious actions, it is <a href="https://www.benzinga.com/markets/macro-economic-events/25/06/45900295/this-is-another-band-aid-say-experts-questioning-long-term-viability-and-efficacy-of-us-china-trade-deal-china-always-had-this-trump-card">still pending approval</a> from President Donald Trump and Chinese counterpart Xi Jinping.
Derek Scissors, a senior fellow at the American Enterprise Institute, remarked that the deal is merely another "band aid." He further warned that China could easily reinstate the blockade on rare earths. Marc Busch, a professor of international business diplomacy at Georgetown University, added to the concerns, noting that China's rhetoric hasn't shifted, raising doubts regarding the sustainability of negotiations.
Despite the headwinds, the broader point is that the Trump administration, for all its tough talk, likely understands the consequences of unmitigated aggression. The president has previously <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45715677/tom-lee-bets-on-a-new-bull-market-as-trumps-tariff-retreat-fuels-taco-trade-amid-run-it-hot-optimism">issued stern warnings and later walked back</a> the magnitude of his policies. China being the world's second-largest economy, the White House can't afford to act imprudently.
On the other end, the Chinese economy isn't all rainbows and gummy bears either. When tensions first erupted, China was already dealing with serious issues, such as <a href="https://www.benzinga.com/markets/25/04/45033463/as-china-downplays-trump-tariffs-with-5-growth-target-top-economist-warns-of-90-chance-of-a-us-recession-amid-trade-war">deflation and a prolonged property crisis</a>. Both sides have reason to play ball and that ultimately may be good news for Applied Materials.
<h2 class="wp-block-heading">Statistical Backdrop Smiles Favorably On AMAT Stock</h2>
While narratives provide the context and color surrounding a particular asset or enterprise, they're not great at forecasting market behaviors. Storylines focus on the "why" of an investment. But when it comes to trading, participants of this discipline tend to focus on the "how" — how much, how fast and most importantly, how likely.
With options trading in particular, it's not enough to have confidence that AMAT stock will move in a certain direction. Depending on the specific strategy, the magnitude of movement is critical. At the same time, all options expire. Therefore, the speculated move must occur within the defined window. This makes probability the centerpiece of options market analysis.
Tackling the topic of probabilities isn't easy using traditional methodologies of fundamental and technical analysis. That's because both approaches suffer from the non-stationarity dilemma: the metric of comparison (such as share price or earnings) fluctuates temporally and contextually. Also, pattern-based technical analysis — while offering a visual representation of price behaviors — is not falsifiable.
To remedy this problem, traders can impose stationarity by converting pricing data into market breadth sequences; that is, sequences of accumulative and distributive sessions. Doing so creates a binary ecosystem, where demand profiles are assessed by a simple observation — it's either happening or it's not.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12151610/AMAT-stock-10wk-forecast-1024x576.jpg" alt="" class="wp-image-948180" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12151610/AMAT-stock-10wk-forecast-1024x576.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12151610/AMAT-stock-10wk-forecast-300x169.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12151610/AMAT-stock-10wk-forecast-768x432.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12151610/AMAT-stock-10wk-forecast.jpg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Image by author</figcaption></figure>
Currently, AMAT stock is on course to print a "6-4-U" sequence: six up weeks, four down weeks, with a net positive trajectory across the 10-week period. In 56.67% of cases, the following week's price action results in upside, with a median return of 2.26%. Assuming that AMAT closes this Friday at $175, it could potentially rise to just under $179 in short order, perhaps a week or two.
Should the bulls maintain control of the market, historical trends suggest that AMAT stock could push toward the $181 level in the next three to four weeks.
<h2 class="wp-block-heading">An Optimistic But Sensible Trade For Applied Materials</h2>
Based on the market intelligence above, the multi-leg options strategy that arguably stands out the most is the 177.50/180 bull call spread expiring July 11. This transaction involves buying the $177.50 call and simultaneously selling the $180 call, for a net debit paid of $125. Should AMAT stock rise through the short strike price ($180) at expiration, the maximum reward is also $125, a payout of 100%.
Primarily, this trade is attractive because of the statistical response to the 6-4-U sequence. With the fundamentals also aligning positively, AMAT stock in theory should have enough fuel to trigger the short strike price at expiration.
Further, the 6-4-U represents a positive uptick in terms of sentiment regime. As a baseline, the chance that a long position will be profitable over any given week is 54%. With the aforementioned sequence, the bullish trader receives almost 3 percentage points of favorable odds.
Granted, it's not the biggest advantage. However, the advantage is still on the bulls' side, incentivizing a long-side debit strategy. As well, the political backdrop adds credibility to the argument.
The opinions and views expressed in this content are those of the individual author and do not necessarily reflect the views of Benzinga. Benzinga is not responsible for the accuracy or reliability of any information provided herein. This content is for informational purposes only and should not be misconstrued as investment advice or a recommendation to buy or sell any security. Readers are asked not to rely on the opinions or information herein, and encouraged to do their own due diligence before making investing decisions.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/options/25/06/45893665/mrvl-stock-trade-agreement-sleeper-options-opportunity">Options Corner: Why The Latest U.S.-China Trade Agreement Makes Marvell A Sleeper Opportunity</a></li>
</ul>
Photo: Shutterstock

Equities

Long Ideas

Options

AMAT

Options Corner: Diplomatic Progress Clears The Path For This Call Spread On Applied Materials

<a href="https://trumpstruth.org/statuses/31488">https://trumpstruth.org/statuses/31488</a>

President Trump Says We Remain Committed To A Diplomatic Resolution To Iran Nuclear Issue; My Entire Administration Has Been Directed To Negotiate With Iran; Iran First Must Completely Give Up Hopes Of Obtaining A Nuclear Weapon

Press Releases

Elicio Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

Health Care

Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment

Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024

Elicio Therapeutics Reaches Alignment with FDA on ELI-002 Registrational Strategy

Financing

Elicio Therapeutics Announces $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Management

Elicio Therapeutics Appoints Preetam Shah, Ph.D., MBA, as Chief Strategy and Financial Officer

Elicio Therapeutics Reports 2024 Financial Results and Provides Corporate Updates

Elicio Therapeutics Reports Inducement Grant to New Chief Strategy and Financial Officer and Other New Hires

Elicio Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Updates

Elicio Therapeutics Secures $10 Million in Financing

Achieve Life Sciences, Inc. - Common Shares

Achieve Life Sciences

Agenus

Anixa Biosciences

Assembly Biosciences, Inc. - Common Stock

Assembly Biosciences

Atossa Therapeutics

Black Diamond Therapeutics, Inc. - Common Stock

Black Diamond Therapeutic

BeyondSpring

Cellectis S.A. - American Depositary Shares

Cellectis

Corbus Pharmaceuticals Holdings, Inc. - Common Stock

Corbus Pharmaceuticals

Caribou Biosciences

EXoZymes

Greenwich LifeSciences, Inc. - Common stock

Greenwich LifeSciences

TuHURA Biosciences

Ironwood Pharmaceuticals, Inc. - Class A Common Stock

Ironwood Pharmaceuticals

Korro Bio

Kyverna Therapeutics, Inc. - Common Stock

Kyverna Therapeutics

Lyell Immunopharma

Molecular Partners AG - American Depositary Shares

Molecular Partners

Nkarta

Protalix BioTherapeutics, Inc. (DE) Common Stock

Protalix BioTherapeutics

ProKidney Corp. - Class A Ordinary Shares

ProKidney

RAPT Therapeutics

Sangamo Therapeutics, Inc. - Common Stock

Sangamo Therapeutics

Protara Therapeutics, Inc. - Common Stock

Protara Therapeutics

Vaxart

HC Wainwright & Co.

Jones Trading

Screenshot 2024-06-07 at 5.22.00 PM

Biotech

Elicio Therapeutics Unveils Promising Phase 1a Data For ELI-002 7P In mKRAS Tumors

Screenshot 2024-04-10 at 5.39.01 PM

Elicio Therapeutics (NASDAQ: ELTX) Makes Strides In Growing Cancer Vaccination Industry

Screenshot 2024-04-04 at 5.26.54 PM

Unlocking The Power Of Immunotherapy: Elicio Therapeutics&#39; (NASDAQ: ELTX) Novel AMP Platform

Comments

Elicio Therapeutics

Noticias

Últimas noticias sobre Elicio Therapeutics (NASDAQ:ELTX) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL